Evan Castiglia

Prepare for Meeting →

Partner

Thuja Capital

Check size: Thuja Capital does not publish a standard check-size range on its current official site.

Investment Thesis

Evan Castiglia invests or supports investment decisions through Thuja Capital's published strategy: Back European biotech and medtech founders translating scientific breakthroughs into products that can reach patients and improve healthcare.

What Excites Them

Strong science, differentiated intellectual property, experienced teams and a credible path from laboratory validation to clinical and commercial impact.

What They Pass On

The published strategy centers on European early-stage biotech and medtech; opportunities outside life sciences or without defensible science are less aligned.

How to Pitch

Show the unmet need, scientific evidence, IP position, development and regulatory plan, team capability, capital requirements and path to patient impact.

Notable Writing

No writing has been linked yet. Kit can search for posts, interviews, and fund essays worth reading before outreach.

Podcast Appearances

No podcast appearances are linked yet. Ask Kit to check for interviews that reveal how this investor thinks.

Key Quotes

Quote coverage is incomplete. Kit can look for direct comments on markets, founders, and investment criteria.

Background

Evan Castiglia is a current Partner at Thuja Capital, according to the firm's official roster. No education, prior employment or personal deal claims are inferred where the firm does not publish them.

Share
Requests are processed by our agent pipeline nightlyIs this you? Request removal